poloxamer
Sign in to savethumb|General structurewith a = 2–130 and b = 15–67
Research
6,711 papers- A review of poloxamer 407 pharmaceutical and pharmacological characteristics.Pharmaceutical research · 2006
- Poloxamer 188 as surfactant in biological formulations - An alternative for polysorbate 20/80?International journal of pharmaceutics · 2022
- Poloxamer: A versatile tri-block copolymer for biomedical applications.Acta biomaterialia · 2020
- Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications.Drug discovery today · 2019
- Purified poloxamer 188 for sickle cell vaso-occlusive crisis.The Annals of pharmacotherapy · 2004
via PubMed
Wikidata facts
Show 1 more fact
- Commons category
- Poloxamers
Sources (2)
via Wikidata · CC0
~11 min read
Article
10 sectionsContents
- Common poloxamer properties
- Micellization and phase transitions
- Uses
- Biological effect
- On multi drug resistant cancer cells
- On nuclear factor kappa B
- Potential degradation by sonication
- References
- Further reading
- External links
thumb|General structurewith a = 2–130 and b = 15–67
Poloxamers are nonionic triblock copolymers composed of a central hydrophobic chain of polyoxypropylene (poly(propylene oxide)) flanked by two hydrophilic chains of polyoxyethylene (poly(ethylene oxide)). The word was coined by BASF inventor, Irving Schmolka, who received the patent for these materials in 1973. Poloxamers are also known by the trade names Pluronic, Kolliphor (pharma grade), and Synperonic.
Available in 9 languages
via Wikidata sitelinks · CC0
Connections
micelles
Entity
polyethylene glycol
Entity
digital object identifier
Entity
International Standard Serial Number
Entity
Q180686
Entity
colloid
Entity
bibcode
Entity
molecular mass
Entity
surfactant
Entity
BASF
Company
Q229883
Entity
phase diagram
Entity
hydrophobe
Entity
cell culture
Entity
Q22908627
Entity
copolymer
Entity
doxorubicin
Entity
hydrophile
Entity
Handle System
Entity
amphiphilic entity
Entity